CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Orexigen Therapeutics, Inc.  (OREX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

OREX's Revenue Year on Year Growth by Quarter and Year

Orexigen Therapeutics,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
OREX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 13.88 4.93 22.95
III Quarter September - 7.00 9.97 30.86
II Quarter June 23.36 7.79 5.19 0.86
I Quarter March 19.15 5.03 4.36 0.86
FY   42.51 33.70 24.45 55.53

Financial Statements
Orexigen Therapeutics,'s second quarter 2017 Revenue $ 23.36 millions OREX's Income Statement
Orexigen Therapeutics,'s second quarter 2016 Revenue $ 7.79 millions Quarterly OREX's Income Statement
OREX's Growth by Division See OREX's Growth by Segment

OREX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 181.54 % -78.52 % 2568.6 %
III Quarter September - -29.79 % -67.69 % 3488.37 %
II Quarter June 199.82 % 50.1 % 503.49 % 0 %
I Quarter March 280.72 % 15.37 % 406.98 % 0 %
FY   - 37.83 % -55.97 % -



OREX Revenue Growth Comment
Orexigen Therapeutics, Inc. reported Revenue surge of 199.82% year on year in the second quarter, to $ 23.36 millions, this is lower than Orexigen Therapeutics, Inc.'s recent average Revenue surge of 419.13%.

Looking into second quarter results within Major Pharmaceutical Preparations industry 20 other companies have achieved higher Revenue growth. While Orexigen Therapeutics, Inc.' s Revenue doubling of 199.82% ranks overall at the positon no. 137 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #21
Healthcare Sector #36
Overall #137
Revenue Y/Y Growth Statistics
High Average Low
3500.58 % 419.13 % -78.51 %
(Sep 30 2014)   (Dec 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OREX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for OREX's Competitors
Revenue Growth for Orexigen Therapeutics,'s Suppliers
Revenue Growth for OREX's Customers

You may also want to know
OREX's Annual Growth Rates OREX's Profitability Ratios OREX's Asset Turnover Ratio OREX's Dividend Growth
OREX's Roe OREX's Valuation Ratios OREX's Financial Strength Ratios OREX's Dividend Payout Ratio
OREX's Roa OREX's Inventory Turnover Ratio OREX's Growth Rates OREX's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Corindus Vascular Robotics, Inc.  344.49 %$ 344.488 millions
Otonomy, Inc.  328.95 %$ 328.947 millions
Zogenix, Inc.  241.24 %$ 241.236 millions
Steadymed Ltd.  239.36 %$ 239.362 millions
Arbutus Biopharma Corp  236.25 %$ 236.246 millions
Apollo Medical Holdings, Inc.  236.05 %$ 236.054 millions
Neos Therapeutics, Inc.  230.57 %$ 230.572 millions
Inovio Pharmaceuticals, Inc.  229.03 %$ 229.027 millions
Chemocentryx, Inc.  219.75 %$ 219.750 millions
Ptc Therapeutics, Inc.  206.80 %$ 206.800 millions
Bellicum Pharmaceuticals, Inc.  203.96 %$ 203.960 millions
Cti Biopharma Corp.  201.93 %$ 201.929 millions
Orexigen Therapeutics, Inc.  199.78 %$ 199.782 millions
Enzon Pharmaceuticals, Inc.  198.20 %$ 198.195 millions
Cytomx Therapeutics, Inc.  182.87 %$ 182.870 millions
Regenxbio Inc.  176.29 %$ 176.295 millions
Hci Viocare  175.23 %$ 175.234 millions
American Cryostem Corp  172.48 %$ 172.478 millions
Exact Sciences Corp  172.11 %$ 172.108 millions
Ionis Pharmaceuticals Inc  170.74 %$ 170.736 millions
Novavax Inc  168.74 %$ 168.743 millions
Amyris, Inc.  167.52 %$ 167.517 millions
Invitae Corp  156.87 %$ 156.872 millions
Biolargo, Inc.  156.45 %$ 156.446 millions
Lifestyle Medical Network, Inc.  153.16 %$ 153.158 millions
Rewalk Robotics Ltd.  145.65 %$ 145.655 millions
Viewray, Inc.  133.44 %$ 133.445 millions
Psivida Corp.  130.59 %$ 130.592 millions
Second Sight Medical Products Inc  115.62 %$ 115.622 millions
American Cannabis Company, Inc.  114.76 %$ 114.760 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MEDI's Profile

Stock Price

MEDI's Financials

MEDI's Expectations

Business Description

Fundamentals

Charts & Quotes

MEDI's News

Suppliers

MEDI's Competitors

Customers & Markets

Economic Indicators

MEDI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com